Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.

Research shows how specific natural nootropics can enhance memory, focus, and cognitive processing while potentially offering ...

Dementia with Lewy bodies (DLB) is a complex condition that shares features with both Alzheimer’s disease and Parkinson’s ...

Inflammation may be at the core of cognitive decline as recent studies offer clues on how herpes simplex virus-1, antibiotics, antivirals, and vaccines may have different effect on dementia risk.

A groundbreaking study from University School of Medicine reveals that just 3½ years of intensive blood pressure control can ...

Cognitive impairment is common in untreated MS patients, affecting 1 in 4, with rates particularly higher in those with SPMS, ...

Alpha Cognition (ACOG) announced the official commercial launch of ZUNVEYL, a new treatment for mild to moderate Alzheimer’s disease. This ...

There are potential interventions for slowing age-related cognitive decline, including medications and lifestyle changes. A new study has found that because of the way the brain gets older ...

The anti-amyloid therapy gantenerumab lowered the chances for developing Alzheimer’s-related dementia in people at high risk for the disease, according to a small study conducted by the Knight Family ...

Kefir, a probiotic-rich fermented milk, shows potential in reducing neuroinflammation, oxidative stress, and beta-amyloid ...